Fair value (multi-method)
Four independent methods triangulate what TMO is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$278.17
Method range
$118.08 – $743.48
median $431.68
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $278.17 | -47.16% |
| Exit multiple | $743.48 | +41.22% |
| Analyst target | $585.18 | +11.15% |
| Graham number | $118.08 | -77.57% |
- Forward DCF$278.17
- Exit multiple$743.48
- Analyst target$585.18
- Graham number$118.08
Stock price
$526.46
EPS (TTM)
$18.19
5Y EPS CAGR
2.1%
Fair value @ hist. growth
$278.17
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied EPS growth
10.6%
per year over your projection horizon
Margin of safety -89.3% vs hist-growth DCF
Historical 5Y CAGR
2.1%
Your model implies
10.6%
Next-year analyst consensus
36.6%
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.0% | 7.2% | 6.4% | 5.5% | 4.5% | 3.3% |
| 8.0% | 9.6% | 8.9% | 8.2% | 7.3% | 6.4% |
| 9.0% | 11.8% | 11.2% | 10.6% | 9.9% | 9.1% |
| 10.0% | 13.8% | 13.3% | 12.8% | 12.1% | 11.5% |
| 11.0% | 15.8% | 15.3% | 14.8% | 14.3% | 13.7% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$31B
Total debt − cash
Beta
0.87
Vs market benchmark
Annual diluted EPS
Per-share earnings by fiscal year — last 5 years anchor the CAGR reference above.
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks4.54% TTM
- Dividend Profile0.34% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History8 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.